VVOS News and Press, Vivos Therapeutics Inc. From 02/17/22

Gainers: Aridis Pharmaceuticals ARDS +12%. Rhythm Pharmaceuticals RYTM +12%. Outset Medical (NASDAQ:OM) +10%. Masimo (NASDAQ:MASI) +8%. Vivos Therapeutics (NASDAQ:VVOS) +7%. Losers: 10x Genomics (NASDAQ:TXG) -16%. iSpecimen ISPC -10%. Poseida ...

There's increasing awareness about sleep apnea which bodes well for stocks like ResMed (RMD) and Vivos Therapeutics (VVOS). But which of these two stocks is a better buy now? Read more to find out. ResMed Inc. ( RMD ) develops, manufactures, distributes, and markets medical devices a...

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, today announced the filing of a U...

HIGHLANDS RANCH, Colo., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (“Vivos” or “the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities fo...

3 Penny Stocks to Add to Your Watchlist in Late January With the stock market taking a bearish turn for both penny stocks and blue chips over the past week, investors are working to understand what could happen in the near or distant future. Right now, we are witnessing several major co...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Several penny stocks are on the move Wednesday and we’re diving into the hot news behind that momentum. Source: Shutterstock But before we get too far into this, remember that penny stocks can be incredibly v...

Small- and micro-cap companies take the cake when it comes to cheap stocks to buy. They’re well-known for their risk/reward profile, but they’re also known for their unique trends. Things like “low float stocks” or “ short squeeze stocks ” are m...

Vivos Also Announces Improved Pricing Agreement With SleepImage Dentists and Patients Report Exceptional User Experience with SleepImage Home Sleep Test HIGHLANDS RANCH, Colo., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc . (“Vivos” o...

Vivos Therapeutics (NASDAQ: VVOS) , a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering from mild-to-moderate obstructive sleep apnea (“OSA”) and snoring, today announced that it has recei...

mmRNA is the first and only appliance of its kind covered by Medicare Part of the Vivos System treatment, the mmRNA appliance represents a highly effective, non-surgical, non-invasive, and non-pharmaceutical alternative for patients suffering from OSA and snoring H...